(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-5-guanidinopentanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-5-guanidinopentanoyl]amino]-5-guanidinopentanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]hexanoyl]amino]-5-guanidinopentanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]-3-phenylpropanoyl]amino]-5-guanidinopentanoyl]amino]hexanoyl]amino]hexanamide

ID: ALA4459667

Chembl Id: CHEMBL4459667

PubChem CID: 155527456

Max Phase: Preclinical

Molecular Formula: C123H202N40O19

Molecular Weight: 2545.23

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O

Standard InChI:  InChI=1S/C123H202N40O19/c1-5-75(3)99(162-102(166)83(130)70-81-55-57-82(164)58-56-81)117(181)156-93(53-34-68-145-122(138)139)107(171)150-89(49-24-30-64-129)112(176)163-100(76(4)6-2)118(182)157-94(54-35-69-146-123(140)141)108(172)152-92(52-33-67-144-121(136)137)111(175)160-98(74-80-42-17-10-18-43-80)116(180)161-97(73-79-40-15-9-16-41-79)115(179)153-87(47-22-28-62-127)105(169)149-86(46-21-27-61-126)104(168)151-91(51-32-66-143-120(134)135)110(174)159-95(71-77-36-11-7-12-37-77)113(177)154-88(48-23-29-63-128)109(173)158-96(72-78-38-13-8-14-39-78)114(178)155-90(50-31-65-142-119(132)133)106(170)148-85(45-20-26-60-125)103(167)147-84(101(131)165)44-19-25-59-124/h7-18,36-43,55-58,75-76,83-100,164H,5-6,19-35,44-54,59-74,124-130H2,1-4H3,(H2,131,165)(H,147,167)(H,148,170)(H,149,169)(H,150,171)(H,151,168)(H,152,172)(H,153,179)(H,154,177)(H,155,178)(H,156,181)(H,157,182)(H,158,173)(H,159,174)(H,160,175)(H,161,180)(H,162,166)(H,163,176)(H4,132,133,142)(H4,134,135,143)(H4,136,137,144)(H4,138,139,145)(H4,140,141,146)/t75-,76-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-/m0/s1

Standard InChI Key:  XEKRFEKDOISJIM-YFGSDQGKSA-N

Alternative Forms

  1. Parent:

    ALA4459667

    ---

Associated Targets(Human)

HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Streptococcus sanguinis (314 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus mutans (2687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 2545.23Molecular Weight (Monoisotopic): 2543.6070AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Li C, Zhu C, Ren B, Yin X, Shim SH, Gao Y, Zhu J, Zhao P, Liu C, Yu R, Xia X, Zhang L..  (2019)  Two optimized antimicrobial peptides with therapeutic potential for clinical antibiotic-resistant Staphylococcus aureus.,  183  [PMID:31520928] [10.1016/j.ejmech.2019.111686]

Source